Abstract
Different strategies have been proposed to improve outcomes of potentially resectable carcinoma GEJ and stomach patients, however the best sequence remains unclear. Various strategies have been proposed to improve pathological complete response rates (pCR) in the neoadjuvant setting. In this sense we conducted a prospective pilot study wherein we intensified pre-operative treatment with neo-adjuvant chemo-radiotherapy (NACTRT) and present initial results in the context of compliance, toxicity and outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
